🚀 VC round data is live in beta, check it out!
Dr Agarwals Valuation Multiples
Discover revenue and EBITDA valuation multiples for Dr Agarwals and similar public comparables like Med Life, Aevis Victoria, National Medical Care, Ardent Health and more.
Dr Agarwals Overview
About Dr Agarwals
Dr Agarwal’s Health Care Ltd is engaged in eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products. It offer services such as Surgeries, Cataract surgeries, Refractive surgeries, Other surgeries, and Consultations, diagnoses and non-surgical treatments, Its products services include Sale of opticals and Sale of eye care-related pharmaceutical products. The company is engaged in single segment that is eye care and related services provided from its hospitals which are located in India and Africa. It generates maximum revenue from India.
Founded
2010
HQ
Employees
3.4K
Website
Sectors
Financials (LTM)
EV
$2B
Dr Agarwals Financials
Dr Agarwals reported last 12-month revenue of $225M and EBITDA of $61M.
In the same LTM period, Dr Agarwals generated $61M in EBITDA and $14M in net income.
Revenue (LTM)
Dr Agarwals P&L
In the most recent fiscal year, Dr Agarwals reported revenue of $200M and EBITDA of $54M.
Dr Agarwals expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $225M | XXX | $200M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $83M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 41% | XXX | XXX | XXX |
| EBITDA | $61M | XXX | $54M | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 27% | XXX | XXX | XXX |
| EBIT Margin | 22% | XXX | 13% | XXX | XXX | XXX |
| Net Profit | $14M | XXX | $10M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 5% | XXX | XXX | XXX |
| Net Debt | — | — | $15M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Dr Agarwals Stock Performance
Dr Agarwals has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Dr Agarwals' stock price is $4.77.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -0.4% | XXX | XXX | XXX | $0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDr Agarwals Valuation Multiples
Dr Agarwals trades at 7.0x EV/Revenue multiple, and 25.8x EV/EBITDA.
EV / Revenue (LTM)
Dr Agarwals Financial Valuation Multiples
As of April 18, 2026, Dr Agarwals has market cap of $2B and EV of $2B.
Equity research analysts estimate Dr Agarwals' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Dr Agarwals has a P/E ratio of 104.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 7.0x | XXX | 7.9x | XXX | XXX | XXX |
| EV/EBITDA | 25.8x | XXX | 29.4x | XXX | XXX | XXX |
| EV/EBIT | 31.3x | XXX | 58.9x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 19.1x | XXX | XXX | XXX |
| P/E | 104.4x | XXX | 152.9x | XXX | XXX | XXX |
| EV/FCF | (202.6x) | XXX | 371.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Dr Agarwals Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Dr Agarwals Margins & Growth Rates
Dr Agarwals' revenue in the last 12 month grew by 20%.
Dr Agarwals' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Dr Agarwals' rule of 40 is 47% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dr Agarwals' rule of X is 78% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Dr Agarwals Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 20% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 27% | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | 13% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 47% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 78% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 28% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Dr Agarwals Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Dr Agarwals | XXX | XXX | XXX | XXX | XXX | XXX |
| Med Life | XXX | XXX | XXX | XXX | XXX | XXX |
| Aevis Victoria | XXX | XXX | XXX | XXX | XXX | XXX |
| National Medical Care | XXX | XXX | XXX | XXX | XXX | XXX |
| Ardent Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dr Agarwals M&A Activity
Dr Agarwals acquired XXX companies to date.
Last acquisition by Dr Agarwals was on XXXXXXXX, XXXXX. Dr Agarwals acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Dr Agarwals
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDr Agarwals Investment Activity
Dr Agarwals invested in XXX companies to date.
Dr Agarwals made its latest investment on XXXXXXXX, XXXXX. Dr Agarwals invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Dr Agarwals
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Dr Agarwals
| When was Dr Agarwals founded? | Dr Agarwals was founded in 2010. |
| Where is Dr Agarwals headquartered? | Dr Agarwals is headquartered in India. |
| How many employees does Dr Agarwals have? | As of today, Dr Agarwals has over 3K employees. |
| Who is the CEO of Dr Agarwals? | Dr Agarwals' CEO is Adil Agarwal. |
| Is Dr Agarwals publicly listed? | Yes, Dr Agarwals is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of Dr Agarwals? | Dr Agarwals trades under AGARWALEYE ticker. |
| When did Dr Agarwals go public? | Dr Agarwals went public in 2025. |
| Who are competitors of Dr Agarwals? | Dr Agarwals main competitors are Med Life, Aevis Victoria, National Medical Care, Ardent Health. |
| What is the current market cap of Dr Agarwals? | Dr Agarwals' current market cap is $2B. |
| What is the current revenue of Dr Agarwals? | Dr Agarwals' last 12 months revenue is $225M. |
| What is the current revenue growth of Dr Agarwals? | Dr Agarwals revenue growth (NTM/LTM) is 20%. |
| What is the current EV/Revenue multiple of Dr Agarwals? | Current revenue multiple of Dr Agarwals is 7.0x. |
| Is Dr Agarwals profitable? | Yes, Dr Agarwals is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Dr Agarwals? | Dr Agarwals' last 12 months EBITDA is $61M. |
| What is Dr Agarwals' EBITDA margin? | Dr Agarwals' last 12 months EBITDA margin is 27%. |
| What is the current EV/EBITDA multiple of Dr Agarwals? | Current EBITDA multiple of Dr Agarwals is 25.8x. |
| What is the current FCF of Dr Agarwals? | Dr Agarwals' last 12 months FCF is ($8M). |
| What is Dr Agarwals' FCF margin? | Dr Agarwals' last 12 months FCF margin is (3%). |
| What is the current EV/FCF multiple of Dr Agarwals? | Current FCF multiple of Dr Agarwals is (202.6x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.